Labs / Assays & in vitro testing
Rapafusyn
Baltimore, MD, United States · rapafusyn.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Rapafusyn develops non-degrading molecular glue therapeutics based on its RapaGlues platform for hard-to-drug intracellular and transmembrane targets. It is based in Baltimore, Maryland, on the Johns Hopkins School of Medicine campus, and focuses on programs in oncology, immunology and inflammation, and renal disease.
They take quote requests by email.
What they offer
Molecular glue drug discovery
Discovers non-degrading macrocyclic molecular glues designed to modulate hard-to-drug targets.
Target identification and lead generation
Uses AI-enabled machine learning and a proprietary DNA-encoded library to identify chemical starting points for difficult targets.
Drug development collaboration
Partners with external organizations to advance RapaGlues programs and pipeline candidates.
What they work on
- Modalities
- Small molecule, Cell therapy
- Species and models
- renal disease models
- Scale and capacity
- DEL library of 8+ billion non-degrading glues
- Therapeutic areas
- oncology, immunology & inflammation, renal disease, acute kidney injury, pain
- Sites
- Baltimore, United States
- Address
- 855 N. Wolfe Street Baltimore, MD 21205
- Founded
- 2006
Similar labs. Evotec, MedChem Partners, Aurigene Pharmaceutical Services, EyeCRO
Found in a contract services directory. Listing built from rapafusyn.com. Work here? Claim this listing.